The purpose of this study is to investigate pancreatic cancer. It looks at how changes in serum uric acid levels after surgery might affect patient survival.
This study evaluates the role of serum uric acid as a marker for predicting outcomes in pancreatic cancer patients after surgery. It focuses on understanding the relationship between uric acid levels and cancer progression.
- Who can participate: Adults with confirmed pancreatic cancer who have had specific types of surgery and survived at least 6 weeks post-operation can participate. Exclusion criteria include a history of certain medical conditions or treatments.
- Study details: Participants will have their serum uric acid levels monitored before and after surgery to assess changes, using these changes as a marker for survival outcomes.